🔗 Share this article

An underground economy for unapproved slimming medications is being driven by social media fitness personalities and sellers on communication apps, according to new investigations.

Investigational Drug Gaining Popularity Via Social Media

The experimental drug, which remains in clinical trials, is being promoted by online personalities for its supposed fat-burning properties. Followers are encouraged to message these accounts directly for supplier links, while also receiving discount codes.

Thriving Trade on Messaging Platforms

Separately, a flourishing trade exists on messaging services, where groups with thousands of participants share comparison images, administration instructions and assertions of rapid UK delivery. Sellers market the substance there before redirecting customers to other platforms for purchases.

Learning About The Experimental Drug

This medication is an experimental injectable created by US drugmaker Eli Lilly. The drug affects three intestinal hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies indicate it could help individuals reduce up to 25% of their body weight. Referred to as the “triple G”, the substance is being promoted digitally as the successor to Ozempic.

Medical Professionals Voice Worries

Nevertheless, physicians and pharmacists have cautions that the sale of what is still an unlicensed drug in the United Kingdom is a cause for concern and could result in users administering products of unknown origin.

Several experts said the popularity for retatrutide could be linked to the increasing cost of approved weight loss treatments such as Mounjaro.

Regulatory Status and Enforcement

Selling retatrutide on TikTok or Telegram is illegal in the United Kingdom, as it is an unlicensed medication that must not be marketed or supplied for human use under the Human Medicines Regulations 2012.

Several influencers try to circumvent the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and supply can still breach medicines, advertising, and customer regulations, potentially leading to fines, prosecution or prison.

Platform Response and Content Elimination

Based on the social media company, the platform has removed problematic content and banned related keywords and search suggestions. The organization said it was dedicated to keeping the service safe and allocating resources in strengthening compliance measures.

Online Marketplace Activities

Research also found communities with up to 9,000 members selling retatrutide using the platform's built-in discovery tool, which functions like a public directory. Typing “retatrutide” immediately brings up channels with thousands of members, filled with images of weight loss, glowing testimonials and step-by-step instructions for mixing or injecting at home.

Within moments of entering one group, a seller posted contact information, where the majority of purchases take place. The seller provided an instruction manual and guaranteed shipping within two days. When questioned whether the product was authentic, one seller said: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. Not one inquired about weight, health issues or past usage.

Item Information and Costs

Inside these groups, messages show black plastic packages with Royal Mail stickers, stating to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, prepared at residence with sterile water, or ready-to-use pens usually sold at 160 pounds for 20 milligrams. When questioned how long a pen should last, vendors give contradictory answers varying between a several days to “depends on your body”.

Service Moderation and Security Measures

A spokesperson for the messaging service said it regularly moderated dangerous material on its platform including content that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are injecting materials they cannot confirm. Although the science behind retatrutide is valid, these online products may not include what they advertise,” stated a pharmacy expert, the director of pharmacy at a pharmacy service.

Dr Crystal Wyllie of an online medical service linked the surge in demand to recent price rises for authorized slimming drugs such as Mounjaro. “With prices rising, individuals are using online platforms. But counterfeit injections are extremely dangerous. You can’t be certain what’s contained or whether the environment they were made in was clean,” she said.

Her staff has previously seen individuals injured by self-injection from unverified sources. “We recognize the disappointment, but buying from Telegram or WhatsApp is gambling with your well-being,” said the doctor. “These substances could be contaminated or incorrectly dosed.”

Producer Statement

A spokesperson from the pharmaceutical company said retatrutide was in third stage clinical trials and had not been reviewed or approved by any government authority anywhere in the world. “Consequently at this point no one can market [it] for human use,” they said, noting that any item “falsely representing itself as a company experimental product not yet authorized … may subject patients to potentially serious medical dangers”.